Guest viewing is limited

Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod

Currently reading:
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod

Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
IHR4R3PJQJPABJVZ4QTJWI4STE.jpg

Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after the drugs cost-effectiveness watchdog NICE on Monday gave its blessing.

Continue reading this article about Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod

by Maggie Fick

NHS Forums - For daily discussion by NHS Staff.
 

News About the NHS

Three local NHS CEOs join NHS England as directors

NHS privatisation and PFI - what Lord Darzi’s review missed

I have groundbreaking NHS tech inside me – but then it failed

Similar threads

P
  • Article
NHS to restrict new weight-loss drug Mounjaro to 220,000 patients in England initially Health officials say they are prioritising people with the highest needs for ‘King Kong of weight-loss drugs’ Fewer than 10% of patients in England who are eligible for what has been dubbed the “King Kong...
Replies
0
Views
77
PA Media
P
A
  • Article
Pioneering drug for rare eye cancer gets go-ahead to be offered on NHS Campaigners welcome Nice approval for use of Kimmtrak (tebentafusp) to treat patients with uveal melanoma Hundreds of patients in England with a rare form of eye cancer are to be offered on the NHS a pioneering drug that...
Replies
0
Views
46
Andrew Gregory Health editor
A
L
  • Article
NHS medicines watchdog ‘costing more lives than it saves’ Researchers suggest funding for expensive new drugs may be better spent on existing health services Continue reading this article about NHS medicines watchdog ‘costing more lives than it saves’ by Laura Donnelly Laura...
Replies
0
Views
23
Laura DonnellyLaura Donnelly
L
N
  • Article
Which disease-modifying Alzheimer’s drugs are the most promising? Many drugs in development aim to delay, slow or reverse symptoms, but which are causing the biggest stir? This week England’s health spending watchdog rejected a new Alzheimer’s drug – the second such drug it has turned down...
Replies
0
Views
100
Nicola Davis Science correspondent
N
L
  • Article
Children with muscle-wasting disease to be offered new NHS drug Duchenne muscular dystrophy (DMD) is an incurable genetic condition which causes the muscles to slowly stop working. Most patients will not live past 30. Continue reading this article about Children with muscle-wasting disease to...
Replies
0
Views
26
Luke Chafer
L

Latest Topics

Thread Information

Title
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
Prefix
N/A
Forum
News about the NHS
Start date
Last reply date
Replies
0

Thread Tags

Tags
None

Subscribe to updates from NHS Forums

Back
Top